诺诚健华：预计2025年净利润为6.33亿元左右

Core Viewpoint - The company, Nocera Biopharma, announced that it expects to achieve profitability for the first time in 2025, with a projected net profit of approximately 633 million yuan, an increase of about 1.074 billion yuan compared to the same period last year [1] Financial Performance - The company anticipates total operating revenue of approximately 2.365 billion yuan in 2025, representing a growth of around 134% compared to the previous year [1]